Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome. (2013)

First Author: Di WL
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.195

PubMed Identifier: 24329107

Publication URI: http://europepmc.org/abstract/MED/24329107

Type: Journal Article/Review

Volume: 24

Parent Publication: Human gene therapy. Clinical development

Issue: 4

ISSN: 2324-8637